About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medicines Information
Adverse Drug Reactions
Clinical guidelines
Compliance
Drug Alerts
Drug Interactions
Drug reviews
Drug shortages
Drugs in lactation
Drugs in liver disease
Drugs in paediatrics
Drugs in pregnancy
Drugs in renal failure
FAQs
General Advice
Horizon scanning
Medication errors
Pharmaceutical Industry
Pharmaceutics
Product Discontinuation
Product Licence Changes
Toxicology & poisoning
Travel health
Unlicenced medicines
73 library items
in Product Discontinuation
Filter results by:
Date Published
2012 (4)
2011 (17)
2010 (24)
2009 (22)
2008 (6)
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Product Discontinuation (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 73
Result page:
Previous
|
1
2
3
4
5
6
7
8
|
Next
1.
Marketing authorisation application withdrawn for Megestrol Alkermes™ (megestrol)
Source:
EMA
,
Date published:
14/03/2012
Category:
8.3.2 Progestogens
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
HIV Infection/AIDS
|
Oncology
|
Product Discontinuation
NeLM
Area:
News
Link
2.
MHRA Drug Safety Update: Suspension of marketing authorisation for Teva levothyroxine 100 microgram tablets due to potential reduced efficacy
Source:
MHRA Drug Safety Update
,
Date published:
12/03/2012
Category:
6.2.1 Thyroid hormones
|
Endocrinology
|
Medical staff
|
Pharmaceutics
|
Prescribing and supply of medicines
|
Product Discontinuation
NeLM
Area:
News
Link
3.
EMA recommends suspension of marketing authorisations for meprobamate-containing medicines in the EU
Source:
EMA
,
Date published:
20/01/2012
Category:
4.1.2 Anxiolytics
|
Adverse Drug Reactions
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Mental Health
|
Product Discontinuation
NeLM
Area:
News
Press release
4.
Discontinuation of granisetron (Kytril) infusion 3mg/3ml
Source:
Roche Products Ltd
,
Date published:
19/01/2012
Category:
4.6 Drugs used in nausea and vertigo
|
Nausea and vomiting
|
Product Discontinuation
NeLM
Area:
News
5.
Discontinuation of Estraderm TTS 25® (estradiol) and Estraderm TTS 100® (estradiol) patches
Source:
Personal communication, Novartis Pharmaceuticals UK Limited
,
Date published:
16/12/2011
Category:
6.1.4 Treatment of hypoglycaemia
|
Menopause / hormone replacement therapy (HRT)
|
Product Discontinuation
NeLM
Area:
News
6.
European Medicines Agency recommends suspension of all buflomedil-containing medicines
Source:
European Medicines Agency
,
Date published:
18/11/2011
Category:
2.6.4 Peripheral vasodilators and related drugs
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Peripheral Vascular Disease
|
Product Discontinuation
NeLM
Area:
News
Press release
Link to Q&A
7.
Celgene communication on permanent discontinuation of lepirudin (Refludan®) from 1st April 2012
Source:
Celgene Europe Limited, MHRA
,
Date published:
04/11/2011
Category:
2.8.1 Parenteral anticoagulants
|
Haematology
|
Medical staff
|
Medicines and Healthcare products Regulatory Agency (MHRA)
|
Pharmaceutical Industry
|
Product Discontinuation
NeLM
Area:
Evidence
>
Medication Safety
MHRA - Link to Celgene letter
8.
EMA recommends discontinuation of lacosamide (Vimpat®) 15mg/ml syrup
Source:
European Medicines Agency (EMA)
,
Date published:
23/09/2011
Category:
4.8.1 Control of epilepsy
|
Epilepsy
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Product Discontinuation
NeLM
Area:
News
Press release
9.
EMA recommends discontinuation of lacosamide (Vimpat®) 15mg/ml syrup
Source:
European Medicines Agency (EMA)
,
Date published:
23/09/2011
Category:
4.8.1 Control of epilepsy
|
Epilepsy
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Product Discontinuation
NeLM
Area:
News
Press release
10.
European CHMP agrees to recall of lacosamide (Vimpat) syrup (15mg/ml) due to uneven distribution of drug in some batches
Source:
European Medicines Agency (EMA)
,
Date published:
25/07/2011
Category:
4.8.1 Control of epilepsy
|
Epilepsy
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Medical staff
|
Pharmaceutics
|
Prescribing and supply of medicines
|
Product Discontinuation
NeLM
Area:
News
Press release
Results 1 - 10 of 73
Result page:
Previous
|
1
2
3
4
5
6
7
8
|
Next